X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (678) 678
Publication (100) 100
Book Chapter (7) 7
Conference Proceeding (6) 6
Web Resource (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (287) 287
male (240) 240
female (239) 239
alzheimer's disease (228) 228
aged (222) 222
dementia (169) 169
magnetic resonance imaging (156) 156
neurology (156) 156
neurosciences (154) 154
middle aged (141) 141
medicin och hälsovetenskap (126) 126
medical and health sciences (124) 124
clinical neurology (120) 120
mild cognitive impairment (108) 108
aged, 80 and over (104) 104
mri (93) 93
psychiatry (90) 90
clinical medicine (84) 84
klinisk medicin (84) 84
alzheimers-disease (80) 80
brain (74) 74
neuropsychological tests (72) 72
brain - pathology (71) 71
atrophy (69) 69
geriatrics & gerontology (67) 67
neurologi (65) 65
diagnosis (58) 58
disease progression (53) 53
alzheimer disease - pathology (52) 52
neuroimaging (50) 50
alzheimer disease - diagnosis (49) 49
biomarkers (48) 48
alzheimer’s disease (47) 47
adult (46) 46
cerebrospinal fluid (45) 45
magnetic resonance imaging - methods (45) 45
memory (44) 44
cognition (42) 42
alzheimers disease (40) 40
geriatrics (39) 39
alzheimer disease - genetics (38) 38
neurovetenskaper (38) 38
alzheimer disease - cerebrospinal fluid (37) 37
cognitive ability (36) 36
neurodegenerative diseases (35) 35
risk factors (34) 34
alzheimer disease - physiopathology (33) 33
follow-up studies (33) 33
hippocampus (33) 33
original research article (33) 33
aging (32) 32
radiology, nuclear medicine & medical imaging (32) 32
age (31) 31
alzheimer disease - psychology (31) 31
analysis (30) 30
cognition disorders - diagnosis (30) 30
tau proteins - cerebrospinal fluid (30) 30
medicine (28) 28
pathology (28) 28
risk (28) 28
apolipoproteins e - genetics (27) 27
cerebrospinal-fluid (27) 27
further section (27) 27
severity of illness index (27) 27
amyloid beta-peptides - cerebrospinal fluid (26) 26
biomarkers - cerebrospinal fluid (26) 26
lesions (26) 26
medicin (26) 26
studies (26) 26
basic medicine (25) 25
brain - physiopathology (25) 25
medicinska och farmaceutiska grundvetenskaper (25) 25
reproducibility of results (25) 25
cohort studies (24) 24
longitudinal studies (24) 24
predictive value of tests (24) 24
psychology (24) 24
image processing, computer-assisted (23) 23
cognition disorders - pathology (22) 22
electroencephalography (22) 22
geriatrik (22) 22
leukoaraiosis (22) 22
psykiatri (22) 22
vascular dementia (22) 22
alzheimer disease (21) 21
association (21) 21
genotype (21) 21
medical imaging (21) 21
medical research (21) 21
research (21) 21
brain - diagnostic imaging (20) 20
dementia disorders (20) 20
disease (20) 20
medicine, experimental (20) 20
segmentation (20) 20
age factors (19) 19
alzheimer disease - complications (19) 19
apolipoprotein e (19) 19
brain atrophy (19) 19
disability (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet neurology, ISSN 1474-4422, 2017, Volume 16, Issue 12, pp. 965 - 975
Journal Article
BMJ, ISSN 0959-8138, 2009, Volume 339, Issue jul06 1, pp. b2477 - b2477
Journal Article
Lancet neurology, ISSN 1474-4422, 2009, Volume 8, Issue 7, pp. 619 - 627
Summary Background Alzheimer's disease (AD) pathology is common in patients with amnestic mild cognitive impairment (aMCI) without dementia, but the prevalence... 
Neurology | BIOMARKERS | DEPRESSION | INTERNATIONAL WORKSHOP | DEMENTIA | PHOSPHORYLATED-TAU | SUBTYPES | CLINICAL-DIAGNOSIS | CEREBROSPINAL-FLUID TAU | DIAGNOSTIC-CRITERIA | NORMATIVE DATA | CLINICAL NEUROLOGY | Predictive Value of Tests | Prevalence | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Alzheimer Disease - diagnosis | Sensitivity and Specificity | Amyloid beta-Peptides - cerebrospinal fluid | Female | Cognition Disorders - cerebrospinal fluid | Disability Evaluation | Severity of Illness Index | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Peptide Fragments - cerebrospinal fluid | Biomarkers - analysis | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Disease Progression | Neuropsychological Tests | Peptide Fragments - analysis | Cognition Disorders - diagnosis | Amyloid beta-Peptides - analysis | Aged | tau Proteins - analysis | Biomarkers - cerebrospinal fluid | Cohort Studies | Medical colleges | Medical research | Care and treatment | Neurosciences | Analysis | Medicine, Experimental | Diagnostic imaging | Alzheimer's disease | Prevalence studies (Epidemiology) | Peptide Fragments | Biological Markers | MEDICIN OCH HÄLSOVETENSKAP | tau Proteins | MEDICAL AND HEALTH SCIENCES | diagnosis | Alzheimer Disease | analysis | Amyloid beta-Protein | physiopathology | Cognition Disorders | cerebrospinal fluid
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 12/2007, Volume 78, Issue 12, pp. 1325 - 1330
Background and purpose:Age related white matter changes (ARWMC) are frequent in non-demented old subjects and are associated with impaired cognitive function.... 
Psychiatry and Mental health | Surgery | Clinical Neurology | SURGERY | POPULATION | DEMENTIA | HYPERINTENSITIES | ABNORMALITIES | PSYCHIATRY | RISK | BLOOD-PRESSURE | LESIONS | CLINICAL NEUROLOGY | DECLINE | SMALL-VESSEL DISEASE | AGE | Prevalence | Cerebrovascular Circulation - physiology | Humans | Stroke - complications | Male | Mass Screening - methods | Diabetes Mellitus, Type 2 - epidemiology | Activities of Daily Living | Alzheimer Disease - diagnosis | Stroke - pathology | Brain - blood supply | Cognition Disorders - etiology | Aged, 80 and over | Alzheimer Disease - epidemiology | Female | Stroke - epidemiology | Surveys and Questionnaires | Hypertension - epidemiology | Trail Making Test | Disability Evaluation | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Risk Factors | Neuropsychological Tests | Cognition Disorders - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Magnetic Resonance Imaging | Alcohol Drinking - epidemiology | Brain - pathology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Cognition Disorders - epidemiology | Prevention | Hypertension | Stroke (Disease) | Myelinated neurofibrils | Age factors in disease | Physiological aspects | Influence | Development and progression | Research | Diabetes | Cognition disorders in old age | Stroke | Heart attacks | Standard scores | Memory | Cognitive ability | Regression analysis | Angina pectoris | Risk factors | Alcohol use | Disability | Cognition & reasoning | Older people | Blood pressure | Health risk assessment | Alzheimers disease | Age | Dementia | Paper | Neurologi | rotterdam | lesions | small-vessel disease | abnormalities | Kirurgi | hyperintensities | Neurology | decline | Psykiatri | dementia | risk | blood-pressure | Psychiatry | age
Journal Article
Journal Article
BJU international, ISSN 1464-4096, 2019, Volume 124, Issue 1, pp. 87 - 92
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e22506
... Kloszewska 7 , Hilkka Soininen 8 , Christian Spenger 2 , Simon Lovestone 9 , 10 , Andrew Simmons 9 , 10 , Lars-Olof Wahlund 1 , for the AddNeuroMed consortium... 
BIOMARKERS | GEOMETRICALLY ACCURATE | DIAGNOSIS | HUMAN CEREBRAL-CORTEX | DEMENTIA | ATROPHY | MULTIDISCIPLINARY SCIENCES | SEGMENTATION | ASSOCIATION | CORTICAL THICKNESSES | SEVERITY | Multivariate Analysis | Reproducibility of Results | Follow-Up Studies | Humans | Cognition Disorders - pathology | Magnetic Resonance Imaging - methods | Male | Alzheimer Disease - pathology | Cognition Disorders - diagnosis | Likelihood Functions | Magnetic Resonance Imaging - classification | Sensitivity and Specificity | Least-Squares Analysis | Female | Aged | Temporal Lobe - pathology | Cohort Studies | Advertising executives | Diagnosis | Magnetic resonance imaging | T cells | Alzheimer's disease | Neurosciences | Traumatic brain injury | Nuclear magnetic resonance--NMR | Biomedical research | Cognitive ability | Mental health | Neurobiology | Science | Performance prediction | Plant biology | Cytotoxicity | Lymphocytes T | Multivariate analysis | Atrophy | Metabolites | Spectrum analysis | Older people | Classification | Temporal lobe | Data analysis | Medical imaging | Neurodegenerative diseases | Magnetic resonance | Cortex | Metabolism | Conversion | Studies | Brain research | Hospitals | Biomarkers | Westman, Eric | Clinical medicine | Alzheimers disease | Prostate cancer | Methods | Hippocampus | Geriatrics | Dementia | Nuclear magnetic resonance | NMR
Journal Article